» Articles » PMID: 7572570

Serotonin Syndrome

Overview
Specialty Public Health
Date 1995 Oct 1
PMID 7572570
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Serotonin syndrome is a potentially life-threatening complication of psychopharmacologic drug therapy. The syndrome is produced most often by the concurrent use of two or more drugs that increase brainstem serotonin activity and is often unrecognized because of the varied and nonspecific nature of its symptomatology. Serotonin syndrome is characterized by alterations in cognition, behavior, autonomic nervous system function and neuromuscular activity. Patients with serotonin syndrome usually respond to discontinuation of drug therapy and supportive care alone, but they may require treatment with a specific antiserotonergic drug such as cyproheptadine, methysergide and/or propranolol.

Citing Articles

Multimechanistic Single-Entity Combinations for Chronic Pain Control: A Narrative Review.

Pergolizzi J, Magnusson P, Coluzzi F, Breve F, LeQuang J, Varrassi G Cureus. 2022; 14(6):e26000.

PMID: 35855248 PMC: 9286298. DOI: 10.7759/cureus.26000.


The Serotonin Syndrome: From Molecular Mechanisms to Clinical Practice.

Francescangeli J, Karamchandani K, Powell M, Bonavia A Int J Mol Sci. 2019; 20(9).

PMID: 31075831 PMC: 6539562. DOI: 10.3390/ijms20092288.


Serum Serotonin Abnormality in Depression.

Saldanha D, Kumar N, Ryali V, Srivastava K, Pawar A Med J Armed Forces India. 2016; 65(2):108-12.

PMID: 27408213 PMC: 4921409. DOI: 10.1016/S0377-1237(09)80120-2.


Characterization of electroencephalographic and biochemical responses at 5-HT promoting drug-induced onset of serotonin syndrome in rats.

Ma Z, Rudacille M, Prentice H, Tao R J Neurochem. 2013; 125(5):774-89.

PMID: 23286698 PMC: 4242192. DOI: 10.1111/jnc.12141.


74-year-old woman with new-onset myoclonus.

Zand L, Hoffman S, Nyman M Mayo Clin Proc. 2010; 85(10):955-8.

PMID: 20884828 PMC: 2947969. DOI: 10.4065/mcp.2009.0572.